Literature DB >> 30106535

Efficacy of ibuprofen and codeine + paracetamol to reduce immediate bleaching sensitivity caused by in-office tooth bleaching: A randomized, controlled, double-blind clinical trial.

Samila Neres de Oliveira1, Isauremi Vieira de Assunção1, Boniek Castillo Dutra Borges1.   

Abstract

PURPOSE: To evaluate (1) the efficacy of Ibuprofen and codeine + paracetamol to control immediate bleaching sensitivity caused by in-office tooth bleaching performed with 35% hydrogen peroxide, and (2) tooth shade change caused by 35% hydrogen peroxide.
METHODS: In this randomized, controlled and double blind clinical trial, 60 volunteers were divided into three treatment groups: 400 mg placebo (PL)(n=20), 400 mg ibuprofen (IB)(n=20), or 30 mg codeine + 500 mg paracetamol (CP)(n=20). The volunteers were submitted to two bleaching sessions with 35% hydrogen peroxide in 2 applications of 20 minutes each. In both sessions, the medication was given to the volunteers 1 hour before the bleaching procedure. The sensitivity values were obtained with the analogic visual pain scale. Tooth shade was assessed before and after bleaching. Statistical analysis was done through the one-way ANOVA and Tukey post-hoc tests.
RESULTS: For bleaching sensitivity, there were statistically significant differences among the medications (P< 0.01). The lowest sensitivity means were found in the CP group (PL:4.7 = IB:4.8 > CP:1.0). In regards to tooth shade, participant's teeth were statistically significantly lighter after bleaching than before bleaching (P< 0.01), with no statistically significant difference between the medications (P< 0.05). CLINICAL SIGNIFICANCE: The use of codeine + paracetamol 1 hour before in-office tooth bleaching can drastically reduce immediate sensitivity. Copyright©American Journal of Dentistry.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30106535

Source DB:  PubMed          Journal:  Am J Dent        ISSN: 0894-8275            Impact factor:   1.522


  2 in total

1.  The combined use of systemic analgesic/anti-inflammatory drugs and a bioactive topical desensitizer for reduced in-office bleaching sensitivity without jeopardizing the hydrogen peroxide efficacy: a randomized, triple blinded, split-mouth clinical trial.

Authors:  Isabela Dantas Torres de Araújo; Kaiza de Sousa Santos; Thauan Victor Oliveira das Neves Peixoto; Moan Jéfter Fernandes Costa; Isauremi Vieira de Assunção; Boniek Castillo Dutra Borges
Journal:  Clin Oral Investig       Date:  2021-04-22       Impact factor: 3.573

2.  Topical application of Otosporin® before in-office bleaching: a split mouth, triple-blind, multicenter randomized clinical trial.

Authors:  Michael Willian Favoreto; Laína Vochikovski; Renata Maria Oleniki Terra; Veridiana Silva Campos; Mariana Evangelista Santos; Sônia Saeger Meireles; Alessandra Reis; Alessandro D Loguercio
Journal:  Clin Oral Investig       Date:  2021-10-19       Impact factor: 3.573

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.